Delivery Order SPE2DE24DA017-SPE2D625F3GFQ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $17,602.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for ARTHREX ACP DOUBLE 1S products. This delivery order, without set-aside designation, is expected to be completed by August 27, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $3,025.44 delivery order on August 1, 2025, with an ultimate completion date of August 6, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal program supporting government healthcare systems. The contract carries no set-aside designation, reflecting Arthrex's competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a fixed-price delivery order valued at $72,555.97 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 15, 2025. This delivery order, designated as 4569067580, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, was awarded a delivery order valued at $2,206.71 on September 9, 2025, with an ultimate completion date of September 12, 2025. The contract, identified as 4569377949, is a fixed-price delivery order with economic price adjustment authority and covers suture-related orthopedic products. The order was issued without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, reflecting...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a fixed-price delivery order valued at $5,226.00 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, for the ARTHREX ACP DOUBLE 1S product. The contract, which is not set-aside, carries an ultimate completion date of September 17, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency valued at...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $3,577.60 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of September 12, 2025. The contract, designated as a non-set-aside award, is issued under Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1, 2029. This...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $7,177.50 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of system implementation quadrupel 9mm products and is scheduled for completion by August 15, 2025. This award was not set aside for any specific business...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies based in Naples, Florida, received a delivery order award valued at $5,849.46 from the Defense Logistics Agency's Medical Supply Chain on July 29, 2025. The delivery order, which employs fixed-price pricing with economic price adjustment terms, calls for the delivery of Fibertak products (available in black/blue and blue/black color combinations with multiple units) to Naples, Florida, with an ultimate...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $24,750 fixed-price delivery order with economic price adjustment for the Arthrex ACP Double Syringe System on September 8, 2025, with an ultimate completion date of September 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, reflecting Arthrex's competitive strength in the federal marketplace. The product will be...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F3GFQDelivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a delivery order valued at $10,870.55 for ARTHREX ACP DOUBLE 1S products. Awarded on September 12, 2025, with an ultimate completion date of September 26, 2025, this fixed-price delivery order with economic price adjustment was issued without a set-aside designation. The funding originates from the Defense Logistics Agency's Medical Supply Chain, which supports the Department of Defense's healthcare needs. This delivery order falls under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029. The IDC enables Veterans Affairs medical centers and military healthcare facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic surgical technologies, including implants, arthroscopic instruments, and specialized surgical systems. Arthrex's established presence as a primary supplier to federal healthcare systems, combined with its competitive positioning in the orthopedic medical device market, underscores its role in supporting advanced surgical capabilities across the government healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/12/25 |